IBOGF
Universal Ibogaine Inc., a life sciences company, develops, acquires, and operates addiction treatment clinics in Canada. It undertakes planned clinical trial for research into the use of ibogaine for addiction treatment. The company is headquartered in Calgary, Canada.
| Period | EPS | Revenue | FCF |
|---|---|---|---|
| 2025 Q3 | -0.00 | $700,918 | -$110,365 |
| 2025 Q2 | -0.00 | $371,602 | -$201,569 |
| 2023 Q3 | -0.00 | $428,329 | -$214,886 |
| 2023 Q2 | -0.00 | $41,267 | -$691,384 |
| 2022 Q1 | -0.00 | $0 | -$593,675 |
| 2022 Q4 | -0.03 | $131,200 | -$2M |
| 2022 Q3 | -0.01 | $369,123 | -$848,938 |
| 2022 Q2 | -0.01 | $433,157 | -$1M |